Solventum Corporation (SOLV) Stock Analysis
A live, multi-source view of Solventum Corporation (SOLV): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Solventum Corporation
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms.
Sector: Healthcare · Industry: Medical Instruments & Supplies · United States · 20,584 employees · solventum.com
Key statistics · as of 2026-09-06
As of 2026-09-06, Solventum Corporation (SOLV) had a market capitalization of $15.61B, a trailing P/E of 11.3 (forward 12.7) and a beta of 0.69; the shares traded in a 52-week range of $62.38 – $94.16 (22.9% over the year).
- Market cap
- $15.61B
- Enterprise value
- $20.50B
- Trailing P/E
- 11.3
- Forward P/E
- 12.7
- PEG ratio
- 1.22
- Price / book
- 3.25
- EPS (trailing)
- $8.11
- EPS (forward)
- $7.22
- Payout ratio
- 0.0%
- 52-week range
- $62.38 – $94.16
- 52-week change
- 22.9%
- Beta
- 0.69
- Average volume
- 1.2M
- Shares outstanding
- 170.2M
- Short % of float
- 2.40%
- Profit margin
- 17.3%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-11
In RapidTradeView’s 2026-09-11 scan of the US universe, Solventum Corporation (SOLV) last closed at $87.65 (the last completed close before that scan).
Technicals at the scan: RSI 47 (neutral territory), price -2.5% versus its 20-day average, 20-day versus 50-day average spread +6.2%, MACD histogram -0.57.
Sentiment inputs: 100% of recent Finnhub-scored headlines read bullish; analyst consensus score 60/100.
Next scheduled company event: in 55 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 1 buy and 1 sell of SOLV; corporate insiders filed 0 buys and 0 sells (2 distinct filers, latest disclosure 2026-08-05). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Tommy Tuberville (0B/1S), Alan Armstrong (1B/0S). Who is trading what
RapidTradeView pick record
SOLV has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Solventum Corporation (SOLV) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell SOLV.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.